For disorder remission, a 55-60% reduction or 7-point raw score change on the MGH-HPS was the best predictor, and on the NIMH-TSS, a 65%reductionn or 6-point raw score change was the best indicator of disorder remission.
For example, there are no prevalence figures according to age categories, even although such data combined with incidence data could add to our understanding of the outcome (e.g. mean duration of the disorder, remission rates) [ 8].
All possible PRIME-MD diagnoses according DSM-IV criteria were considered in our study: major depressive disorder, minor depressive disorder, partial remission from a major depressive disorder, dysthymic disorder, bipolar disorder or depression caused by a general medical condition, medication or drugs.
Because the present analysis is conducted in participants with an acute disorder or a disorder in remission only (excluding healthy controls), associations in an unexpected direction merely reflect that the predictor is not so important for that particular disorder in comparison to the other disorders it is compared to.
Background: This study compares the perception of spouses and the quality of the dyadic relationship of patients with severe affective disorders in remission with healthy couples.
The models on disorders in remission showed no differences.
Currently available treatments for these disorders produce remission in only 40-60% of patients [ 2].
Persistent pyrexia in patients with malignant hematological disorders, in remission, may serve as a diagnostic marker for TB [ 14].
Crohn disease-related lymphomas have been shown to have a higher prevalence of EBV-related subtypes, and in some EBV-related lymphoproliferative disorders disease remission has been seen with withdrawal of immunosuppression [ 13].
First scores on all measures were compared between participants meeting criteria for current disorder and participants who did not meet these criteria, as well as comparing participants with a disorder in remission to a control group with no lifetime disorders.
